scorecardresearch
Follow Us:
Saturday, November 27, 2021

Merck & Co. Inc

MERCK & CO. INC NEWS

Merck's experimental COVID-19 pill cuts risk of death, hospitalisation by 50%

October 01, 2021 5:27 pm

Merck said it expects to produce 10 million courses of the treatment by the end of 2021, with more doses coming next year.

Merck & Co to buy Idenix for $3.85 bn

June 10, 2014 1:42 am

Sovaldi, which costs about $84,000 a year per patient, generated $2.3 billion in sales in the first few months on the market.

Vaccine against rotavirus gastroenteritis

March 18, 2011 2:18 am

Pharmaceutical research firm MSD has launched RotaTeq,a pentavalent rotavirus vaccine to prevent rotavirus gastroenteritis.

Advertisement
Advertisement
Advertisement